Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillation — Claudia Rubino (2022) | RDL Network
Safety and efficacy of direct oral anticoagulants (DOACs) in very elderly patients (≥85 years old) with non-valvular atrial fibrillation
Article 2022 en
Authors
CR
Claudia Rubino
FB
Fabiana Blunda
FB
Francesca Bodega
Abstract
1 min read
This single center registry, showed that the use of DOACs in very elderly NVAF was safe and is a therapeutic option to be pursued for stroke prevention especially for those who are at high risk of ischemic events.
Discussion(0)
No comments yet. Be the first to comment.